Challenges in the Treatment of Pediatric Keloids
Michael H. Tirgan, MD
Institutions: Keloid Research Foundation
Corresponding Author:Michael H. Tirgan, MD
23 West 73rd Street, Suite GD, New York, NY 10065
(212) 874 4200
htirgan@gmail.com
Manuscript Word Count:
Conflict of Interest:None
Funding: None
IRB Assessment: Determined by central IRB to be exempt and not requiring IRB approval.
Keywords: Keloid, Keloid Biology, Keloid Registry, Keloid Growth
Background:
Approximately 63% of patients develop their very first keloid before they turn 18, making Keloid Disorder a pediatric chronic skin ailment. As shown in the graph below, children under the age of 10 are not spared and require proper treatment.
Methods:
Keloid removal surgery should be avoided in children at all costs, as it can result in
detrimental outcomes that will be very difficult, if not impossible, to treat at a later date. Contact cryotherapy and intralesional chemotherapy have emerged as promising yet underutilized alternatives in the management of pediatric keloids.